More on BLCO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+114.3% Growth)
- Ratings (4.7 Score)
- Holders

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bausch + Lomb Corporation (NY:BLCO)
Delayed: 14.87 +0.01 (0.07%)
Prev. Close $14.86  
Open$14.88 
52 Wk High$ 
52 Wk Low$ 
Day High$15.00 
Day Low$14.82 
P/E N/A  
EPS$ 
Volume335,472 

Friends, Peers and Foes (?): BHC, DRRX, BMEA, EYEN, OTLK (more...)

Jun 16, 2026 04:17 PM Form 4 Bausch & Lomb Corp For: Jun 12 Filed by: Bonnefoy Luc
Jun 5, 2026 08:49 AM RBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share'
Jun 1, 2026 06:59 AM Bausch + Lomb launches preservative-free dry eye drops in US
Jun 1, 2026 06:59 AM Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
May 28, 2026 05:51 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: VON ESCHENBACH ANDREW C.
May 28, 2026 05:51 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ross Thomas W. Sr.
May 28, 2026 05:51 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: ROBERTSON RUSSEL C
May 28, 2026 05:50 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: Paulson John
May 28, 2026 05:50 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ling Karen
May 28, 2026 05:50 PM Form 4 Bausch & Lomb Corp For: May 26 Filed by: KAVANAGH SARAH B
View All Articles

Entities mentioned with BLCO

View All Entities